Difference between revisions of "LncRNAWiki:Featured"
(95 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
− | {|class="wikitable sortable" style="width:90%;text-align:center" | + | {|class="wikitable sortable" style="width:90%;text-align:center" |
|- | |- | ||
− | ! | + | !width="50"|LncBook ID |
− | ! | + | !width="50"|Symbol |
− | ! | + | !width="50"|Synonyms |
− | ! | + | !width="50"|Functional Mechanism |
+ | !width="50"|Biological Process | ||
+ | !width="50"|Disease | ||
+ | !width="50"|Mesh Ontology | ||
|- | |- | ||
− | |'' | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289501 HSALNT0289501] |
+ | |[[HPVC1]] | ||
+ | |PE5L,HPV18E5L | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289605 HSALNT0289605] | ||
+ | |[[NONHSAT104559]] | ||
+ | |lnc-C9orf53-2:1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199632 HSALNT0199632] | ||
+ | |[[N4BP2L2-IT2]] | ||
+ | |CG030 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0171094 HSALNT0171094] | ||
+ | |[[LINC01150]] | ||
+ | |2G7,TCONS_00019134 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Wilms' tumor | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289115 HSALNT0289115] | ||
+ | |[[LINC01587]] | ||
+ | |C4orf6,aC1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |neuroblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290105 HSALNT0290105] | ||
+ | |[[NONHSAT115106]] | ||
+ | |NONHSAT115106 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289234 HSALNT0289234] | ||
+ | |[[RNF217-AS1]] | ||
+ | |STL | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |acute lymphoblastic leukemia | ||
+ | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0280481 HSALNT0280481] | ||
+ | |[[INE2]] | ||
+ | |NCRNA00011 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289485 HSALNT0289485] | ||
+ | |[[INE1]] | ||
+ | |NCRNA00010 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289511 HSALNT0289511] | ||
+ | |[[LINC01565]] | ||
+ | |C3orf27,GR6 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |leukemia | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289068 HSALNT0289068] | ||
+ | |[[LINC00869]] | ||
+ | |KIAA0493 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289430 HSALNT0289430] | ||
+ | |[[ERC2-IT1]] | ||
+ | |C1orf1,C3orf51,Po42 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290394 HSALNT0290394] | ||
+ | |[[Lnc-PDIA4-1:1]] | ||
+ | |lnc-PDIA4-1:1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289195 HSALNT0289195] | ||
+ | |[[NOP14-AS1]] | ||
+ | |C4orf10,RES4-24 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290309 HSALNT0290309] | ||
+ | |[[NONHSAT022116]] | ||
+ | |NONHSAT022116,AF080092,TSU | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289243 HSALNT0289243] | ||
+ | |[[SMAD5-AS1]] | ||
+ | |SMAD5O,DAMS | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |malignant hematopoietic | ||
+ | |Cell Physiological Phenomena | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289025 HSALNT0289025] | ||
+ | |[[LINC00244]] | ||
+ | |C7orf4,NCRNA00244 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |preaxial polydactyly | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289017 HSALNT0289017] | ||
+ | |[[KIF25-AS1]] | ||
+ | |C6orf54,NCRNA00300,HGC6.1.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289332 HSALNT0289332] | ||
+ | |[[LINC01558]] | ||
+ | |C6orf123,LINC01557,HGC6.2,dJ431P23.4 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289438 HSALNT0289438] | ||
+ | |[[AFDN-AS1]] | ||
+ | |C6orf124,MLLT4-AS1,HGC6.4,dJ431P23.3 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289232 HSALNT0289232] | ||
+ | |[[RFPL3S]] | ||
+ | |RFPL3-AS1,RFPL3-A, NCRNA00005 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |opitz syndrome | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289393 HSALNT0289393] | ||
+ | |[[RFPL1S]] | ||
+ | |RFPL1-AS1,RFPL1-A, NCRNA00006 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289500 HSALNT0289500] | ||
+ | |[[HCG4B]] | ||
+ | |HCG4P6,HCGIV-6,HCGIV.5,HCGIV-06,bCX67J3.3,Em:AB023056.16,bPG309N1.1,bQB90C11.3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289894 HSALNT0289894] | ||
+ | |[[LINC00294]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289345 HSALNT0289345] | ||
+ | |[[LINC00893]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hunter syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290133 HSALNT0290133] | ||
+ | |[[PCBP3-OT1]] | ||
+ | |PCBP3-OT1,FLJ44028 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289488 HSALNT0289488] | ||
+ | |[[ENST00000418282.1]] | ||
+ | |NCRNA00187 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |blepharophimosis syndrome | ||
+ | |Eye Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289712 HSALNT0289712] | ||
+ | |[[COPG2IT1]] | ||
+ | |CIT1,NCRNA00170,COPG2AS | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0265040 HSALNT0265040] | ||
+ | |[[LINC00652]] | ||
+ | |HSPC072 | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289282 HSALNT0289282] | ||
+ | |[[WASIR2]] | ||
+ | |NCRNA00286A | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246856 HSALNT0246856] | ||
+ | |[[LINC00470]] | ||
+ | |C18orf2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |age-related macular degeneration | ||
+ | |Eye Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289507 HSALNT0289507] | ||
+ | |[[LINC00588]] | ||
+ | |C8orf71,DKFZP434F122 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0276604 HSALNT0276604] | ||
+ | |[[TTC28-AS1]] | ||
+ | |TTC28AS,TTC28-AS,KIAA1648 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0237577 HSALNT0237577] | ||
+ | |[[CDRT7]] | ||
+ | |NCRNA00025,LINC00025 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288912 HSALNT0288912] | ||
+ | |[[CDRT8]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275048 HSALNT0275048] | ||
+ | |[[CECR3]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cat eye syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288915 HSALNT0288915] | ||
+ | |[[CECR9]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cat eye syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288998 HSALNT0288998] | ||
+ | |[[HDHD5-AS1]] | ||
+ | |CECR4,CECR5-AS1,NCRNA00017 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cat eye syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288914 HSALNT0288914] | ||
+ | |[[CECR5-AS1]] | ||
+ | |NCRNA00017 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cat eye syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288919 HSALNT0288919] | ||
+ | |[[CLRN1-AS1]] | ||
+ | |CLRN1O,UCRP | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |usher syndrome type 3 | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289271 HSALNT0289271] | ||
+ | |[[TMEM9B-AS1]] | ||
+ | |C11orf18 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289324 HSALNT0289324] | ||
+ | |[[LINC01547]] | ||
+ | |C21orf69,C21orf67 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Down syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0270409 HSALNT0270409] | ||
+ | |[[LINC00029]] | ||
+ | |C20orf51,NCRNA00029,bA305P22.4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289336 HSALNT0289336] | ||
+ | |[[LINC00529]] | ||
+ | |C8orf8 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |keratolytic winter erythema | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288978 HSALNT0288978] | ||
+ | |[[FLVCR1-AS1]] | ||
+ | |FLVCR1-DT,LQK1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0238050 HSALNT0238050] | ||
+ | |[[SMCR2]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Smith-Magenis syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289401 HSALNT0289401] | ||
+ | |[[SMCR5]] | ||
+ | |NCRNA00034 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Smith-Magenis syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290246 HSALNT0290246] | ||
+ | |[[SMCR6]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Smith-Magenis syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274626 HSALNT0274626] | ||
+ | |[[LINC00205]] | ||
+ | |C21orf86,NCRNA00205, | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271512 HSALNT0271512] | ||
+ | |[[C21orf91-OT1]] | ||
+ | |NCRNA00285,D21S2089E | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0272596 HSALNT0272596] | ||
+ | |[[LINC00307]] | ||
+ | |NCRNA00307,D21S2091E | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274502 HSALNT0274502] | ||
+ | |[[TSPEAR-AS2]] | ||
+ | |C21orf90 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274807 HSALNT0274807] | ||
+ | |[[MCM3AP-AS1]] | ||
+ | |C21orf85,MCM3APAS,MCM3AP-AS,FLJ10508,NCRNA00031 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288888 HSALNT0288888] | ||
+ | |[[B3GALT5-AS1]] | ||
+ | |C21orf88 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288898 HSALNT0288898] | ||
+ | |[[BRWD1-AS2]] | ||
+ | |C21orf87,NCRNA00257,BRWD1-IT2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289031 HSALNT0289031] | ||
+ | |[[LINC00315]] | ||
+ | |C21orf93,NCRNA00315 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289033 HSALNT0289033] | ||
+ | |[[LINC00334]] | ||
+ | |C21orf89,NCRNA00334 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289322 HSALNT0289322] | ||
+ | |[[LINC00314]] | ||
+ | |C21orf94,NCRNA00314 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271821 HSALNT0271821] | ||
+ | |[[LINC00308]] | ||
+ | |C21orf74,NCRNA00308,PRED16 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289023 HSALNT0289023] | ||
+ | |[[LINC00189]] | ||
+ | |C21orf109,NCRNA00189 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289375 HSALNT0289375] | ||
+ | |[[NCRUPAR]] | ||
+ | |ncR-uPAR,ncRuPAR,NCRNA00193 | ||
+ | |transcriptional regulation | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273467 HSALNT0273467] | ||
+ | |[[DSCR10]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289480 HSALNT0289480] | ||
+ | |[[DSCR9]] | ||
+ | |NCRNA00038 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290051 HSALNT0290051] | ||
+ | |[[MDS2]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |myelodysplastic syndrome | ||
+ | |Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127810 HSALNT0127810] | ||
+ | |[[ST7-AS2]] | ||
+ | |ST7OT2,ST7AS2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |autism | ||
+ | |Mental Disorders | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127813 HSALNT0127813] | ||
+ | |[[ST7-OT3]] | ||
+ | |ST7OT3,NCRNA00026 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |autism | ||
+ | |Mental Disorders | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290258 HSALNT0290258] | ||
+ | |[[ST7-OT4]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |autism | ||
+ | |Mental Disorders | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290257 HSALNT0290257] | ||
+ | |[[NONHSAT122926]] | ||
+ | |NONHSAT122926 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289372 HSALNT0289372] | ||
+ | |[[MIR600HG]] | ||
+ | |C9orf45,NCRNA00287,GL012,FLJ22161 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013239 HSALNT0013239] | ||
+ | |[[ATP1A1-AS1]] | ||
+ | |C1orf203,ATP1A1OS,MGC16179 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0048563 HSALNT0048563] | ||
+ | |[[SPATA3-AS1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050859 HSALNT0050859] | ||
+ | |[[LINC00852]] | ||
+ | |C3orf42,GHRLOS2,NAG73,GHRL-AS2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0069395 HSALNT0069395] | ||
+ | |[[LINC01096]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072367 HSALNT0072367] | ||
+ | |[[LINC02260]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0077259 HSALNT0077259] | ||
+ | |[[LINC01091]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096480 HSALNT0096480] | ||
+ | |[[SAP30L-AS1]] | ||
+ | |FLJ38109,GALNT10-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0098558 HSALNT0098558] | ||
+ | |[[PRR7-AS1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0099356 HSALNT0099356] | ||
+ | |[[LINC01622]] | ||
+ | |TCONS_00011202 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0113415 HSALNT0113415] | ||
+ | |[[LINC01312]] | ||
+ | |MGC34034 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134652 HSALNT0134652] | ||
+ | |[[EXTL3-AS1]] | ||
+ | |C8orf50 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138253 HSALNT0138253] | ||
+ | |[[C8orf34-AS1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154876 HSALNT0154876] | ||
+ | |[[PSMD5-AS1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0163228 HSALNT0163228] | ||
+ | |[[LINC01553]] | ||
+ | |C10orf40,AC023904.2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0175689 HSALNT0175689] | ||
+ | |[[LINC00301]] | ||
+ | |C11orf64,NCRNA00301,MGC39681 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247235 HSALNT0247235] | ||
+ | |[[DLGAP1-AS3]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0254200 HSALNT0254200] | ||
+ | |[[CIRBP-AS1]] | ||
+ | |C19orf23,MGC39338 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0257335 HSALNT0257335] | ||
+ | |[[LINC01785]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0261582 HSALNT0261582] | ||
+ | |[[LINC01869]] | ||
+ | |MGC45922 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0269743 HSALNT0269743] | ||
+ | |[[LINC01711]] | ||
+ | |MGC4294 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288468 HSALNT0288468] | ||
+ | |[[FAM41AY1]] | ||
+ | |FAM41AY | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288899 HSALNT0288899] | ||
+ | |[[C5orf66-AS2]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288922 HSALNT0288922] | ||
+ | |[[CSTF3-AS1]] | ||
+ | |CSTF3-DT | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288923 HSALNT0288923] | ||
+ | |[[CYP1B1-AS1]] | ||
+ | |C2orf58,MGC34824 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288957 HSALNT0288957] | ||
+ | |[[ENTPD3-AS1]] | ||
+ | |FLJ36665 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288970 HSALNT0288970] | ||
+ | |[[FAM27E3]] | ||
+ | |MGC42630 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288972 HSALNT0288972] | ||
+ | |[[FAM41C]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288977 HSALNT0288977] | ||
+ | |[[FLG-AS1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288983 HSALNT0288983] | ||
+ | |[[GABPB1-IT1]] | ||
+ | |FLJ10038 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289010 HSALNT0289010] | ||
+ | |[[ILF3-AS1]] | ||
+ | |ILF3-DT | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289034 HSALNT0289034] | ||
+ | |[[LINC00347]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289039 HSALNT0289039] | ||
+ | |[[LINC00466]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289040 HSALNT0289040] | ||
+ | |[[LINC00471]] | ||
+ | |C2orf52,MGC43122 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289044 HSALNT0289044] | ||
+ | |[[LINC00526]] | ||
+ | |C18orf18,MGC17515,HsT959 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289048 HSALNT0289048] | ||
+ | |[[LINC00593]] | ||
+ | |C15orf50,MGC42951 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289050 HSALNT0289050] | ||
+ | |[[LINC00608]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289054 HSALNT0289054] | ||
+ | |[[LINC00638]] | ||
+ | |MGC23270 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289056 HSALNT0289056] | ||
+ | |[[LINC00661]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289057 HSALNT0289057] | ||
+ | |[[LINC00662]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289062 HSALNT0289062] | ||
+ | |[[LINC00692]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289064 HSALNT0289064] | ||
+ | |[[LINC00705]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289067 HSALNT0289067] | ||
+ | |[[LINC00868]] | ||
+ | |C17orf52 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0130693 HSALNT0130693] | ||
+ | |[[LINC00996]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289101 HSALNT0289101] | ||
+ | |[[LINC01252]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289131 HSALNT0289131] | ||
+ | |[[LINC02135]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289193 HSALNT0289193] | ||
+ | |[[NIFK-AS1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289244 HSALNT0289244] | ||
+ | |[[SMG7-AS1]] | ||
+ | |DKFZP564C196 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235326 HSALNT0235326] | ||
+ | |[[SNAI3-AS1]] | ||
+ | |MGC23284 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0215205 HSALNT0215205] | ||
+ | |[[SNHG10]] | ||
+ | |C14orf62,FLJ40557,NCRNA00063,LINC00063 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289290 HSALNT0289290] | ||
+ | |[[ZNF205-AS1]] | ||
+ | |MGC3771 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289294 HSALNT0289294] | ||
+ | |[[LINC00260]] | ||
+ | |C1orf217,NCRNA00260,MGC5457 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289295 HSALNT0289295] | ||
+ | |[[LINC00337]] | ||
+ | |C1orf211,NCRNA00337,MGC40168 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289298 HSALNT0289298] | ||
+ | |[[WAC-AS1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289299 HSALNT0289299] | ||
+ | |[[LINC00839]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289303 HSALNT0289303] | ||
+ | |[[LINC00612]] | ||
+ | |C12orf33,MGC40170,FLJ41814 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289312 HSALNT0289312] | ||
+ | |[[LINC00663]] | ||
+ | |MGC39821 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289320 HSALNT0289320] | ||
+ | |[[LINC00494]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289330 HSALNT0289330] | ||
+ | |[[LINC01019]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289333 HSALNT0289333] | ||
+ | |[[LINC00265]] | ||
+ | |NCRNA00265,NCRNA00265-1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289334 HSALNT0289334] | ||
+ | |[[LINC00689]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289337 HSALNT0289337] | ||
+ | |[[LINC01591]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289340 HSALNT0289340] | ||
+ | |[[LINC01501]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289346 HSALNT0289346] | ||
+ | |[[LINC01560]] | ||
+ | |CXorf24 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289352 HSALNT0289352] | ||
+ | |[[LINC01959]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289353 HSALNT0289353] | ||
+ | |[[LINC02175]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289354 HSALNT0289354] | ||
+ | |[[LINC02209]] | ||
+ | |FAM183CP | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289359 HSALNT0289359] | ||
+ | |[[LINGO1-AS1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289362 HSALNT0289362] | ||
+ | |[[MAFG-AS1]] | ||
+ | |MAFG-DT | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289373 HSALNT0289373] | ||
+ | |[[MORF4L2-AS1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289381 HSALNT0289381] | ||
+ | |[[NPHP3-AS1]] | ||
+ | |NCRNA00119 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289385 HSALNT0289385] | ||
+ | |[[PAXIP1-AS1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289413 HSALNT0289413] | ||
+ | |[[TOLLIP-AS1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289416 HSALNT0289416] | ||
+ | |[[LINC00311]] | ||
+ | |TMEM148,NCRNA00311,MGC22001 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289422 HSALNT0289422] | ||
+ | |[[ZNF252P-AS1]] | ||
+ | |C8orf77 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289423 HSALNT0289423] | ||
+ | |[[ZNF436-AS1]] | ||
+ | |C1orf213,FLJ90508 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289429 HSALNT0289429] | ||
+ | |[[BFSP2-AS1]] | ||
+ | |MGC2848 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289432 HSALNT0289432] | ||
+ | |[[CTBP1-DT]] | ||
+ | |C4orf42,CTBP1-AS1,CTBP1-DT,MGC21675 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289436 HSALNT0289436] | ||
+ | |[[EXOC3-AS1]] | ||
+ | |C5orf55 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289441 HSALNT0289441] | ||
+ | |[[HCG27]] | ||
+ | |bPG299F13.9,bCX101P6.9,bQB115I13.2,FLJ40123 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289450 HSALNT0289450] | ||
+ | |[[BAALC-AS2]] | ||
+ | |C8orf56,BAALCOS,MGC39526 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289453 HSALNT0289453] | ||
+ | |[[FAM87A]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289459 HSALNT0289459] | ||
+ | |[[JMJD1C-AS1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289465 HSALNT0289465] | ||
+ | |[[ATP2B1-AS1]] | ||
+ | |LINC00936 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289466 HSALNT0289466] | ||
+ | |[[CEP83-AS1]] | ||
+ | |CEP83-DT | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289470 HSALNT0289470] | ||
+ | |[[HEXA-AS1]] | ||
+ | |C15orf34,FLJ13315 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289487 HSALNT0289487] | ||
+ | |[[BIN3-IT1]] | ||
+ | |FLJ14107 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289490 HSALNT0289490] | ||
+ | |[[CSNK1G2-AS1]] | ||
+ | |C19orf34,MGC39696 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289508 HSALNT0289508] | ||
+ | |[[LINC00634]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289510 HSALNT0289510] | ||
+ | |[[LINC00685]] | ||
+ | |CXYorf10,NCRNA00107,PPP2R3B-AS1,OTTHUMT00000055574 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289515 HSALNT0289515] | ||
+ | |[[SHANK2-AS3]] | ||
+ | |C11orf76 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290073 HSALNT0290073] | ||
+ | |[[NCBP2-AS2]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289502 HSALNT0289502] | ||
+ | |[[NONHSAT095745]] | ||
+ | |NCRNA00099,UM9-5 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289856 HSALNT0289856] | ||
+ | |[[GTSCR1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Gilles de la Tourette syndrome | ||
+ | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289325 HSALNT0289325] | ||
+ | |[[LINC00272]] | ||
+ | |C1orf120,NCRNA00272,RP1-223H12.3 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288512 HSALNT0288512] | ||
+ | |[[TTTY9B]] | ||
+ | |NCRNA00132 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290155 HSALNT0290155] | ||
+ | |[[Prion-associated RNAs]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prion disease | ||
+ | |Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289444 HSALNT0289444] | ||
+ | |[[BLACE]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |acute B lymphoblastic leukemias | ||
+ | |Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060411 HSALNT0060411] | ||
+ | |[[H1FX-AS1]] | ||
+ | |C3orf47,FLJ34151 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0186668 HSALNT0186668] | ||
+ | |[[LINC00477]] | ||
+ | |C12orf67,FLJ32894,FAM191B | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275096 HSALNT0275096] | ||
+ | |[[LINC00528]] | ||
+ | |C22orf37,FLJ40542 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287824 HSALNT0287824] | ||
+ | |[[ASMTL-AS1]] | ||
+ | |CXYorf2,NCRNA00105,ASMTLAS,ASMTL-AS,FLJ13330 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288887 HSALNT0288887] | ||
+ | |[[ANP32A-IT1]] | ||
+ | |C15orf28,NCRNA00321,FLJ11722,HsT18971 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289396 HSALNT0289396] | ||
+ | |[[RUSC1-AS1]] | ||
+ | |C1orf104,FLJ35976 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084628 HSALNT0084628] | ||
+ | |[[LINC01194]] | ||
+ | |CT49,TAG | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |melanoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289468 HSALNT0289468] | ||
+ | |[[NONHSAT040032]] | ||
+ | |C14orf134,NCRNA00041,DIO3-AS1,NONHSAT040032,NONHSAT040039,BC111049 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0121060 HSALNT0121060] | ||
+ | |[[NPSR1-AS1]] | ||
+ | |AAA1,IMAGE:4827585 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0074370 HSALNT0074370] | ||
+ | |[[LINC00575]] | ||
+ | |C4orf11 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137345 HSALNT0137345] | ||
+ | |[[LINC01602]] | ||
+ | |T1560 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289433 HSALNT0289433] | ||
+ | |[[FAM13A-AS1]] | ||
+ | |FAM13A1OS,FAM13AOS,NCRNA00039 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289186 HSALNT0289186] | ||
+ | |[[MIRLET7DHG]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0155254 HSALNT0155254] | ||
+ | |[[MIR181A2HG]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289283 HSALNT0289283] | ||
+ | |[[WDFY3-AS2]] | ||
+ | |C4orf12,NCRNA00247,FBI4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154555 HSALNT0154555] | ||
+ | |[[PAPPA-AS1]] | ||
+ | |PAPPAS,PAPPA-AS,DIPAS,TAF4B,TAF2C2,TAFII105,NCRNA00156 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0136307 HSALNT0136307] | ||
+ | |[[LINC00293]] | ||
+ | |BEYLA | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030983 HSALNT0030983] | ||
+ | |[[SIX3-AS1]] | ||
+ | |SIX3OS | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211503 HSALNT0211503] | ||
+ | |[[Lnc-C14orf101-5:1]] | ||
+ | |OTX2OS1 | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0063422 HSALNT0063422] | ||
+ | |[[LINC01192]] | ||
+ | |CT64 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217123 HSALNT0217123] | ||
+ | |[[LINC01193]] | ||
+ | |CT60,LOC348120 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289664 HSALNT0289664] | ||
+ | |[[C1QTNF9B-AS1]] | ||
+ | |PCOTH | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289623 HSALNT0289623] | ||
+ | |[[ATP6V1G2-DDX39B]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |dilated cardiomyopathy | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289498 HSALNT0289498] | ||
+ | |[[FAM226B]] | ||
+ | |CXorf50B,NCRNA00246B,LINC00246B | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289321 HSALNT0289321] | ||
+ | |[[LINC00163]] | ||
+ | |C21orf134,NCRNA00163,NLC1-A,NLC1A | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |narcolepsy | ||
+ | |Mental Disorders;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289505 HSALNT0289505] | ||
+ | |[[LINC00165]] | ||
+ | |C21orf135,NCRNA00165,NLC1-B | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290297 HSALNT0290297] | ||
+ | |[[NONHSAT035776]] | ||
+ | |ENSG00000251002 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274212 HSALNT0274212] | ||
+ | |[[LINC00322]] | ||
+ | |C21orf136,NCRNA00322,FLJ16545 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289741 HSALNT0289741] | ||
+ | |[[NONHSAT102417]] | ||
+ | |DHFR minor transcript 5'-UTR,ENSG00000228716,NONHSAT102417 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289527 HSALNT0289527] | ||
|[[NONHSAT128494]] | |[[NONHSAT128494]] | ||
− | |ncRNA 21A | + | |ncRNA 21A,NONHSAT128494 |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289409 HSALNT0289409] | ||
+ | |[[TLX1NB]] | ||
+ | |TD1,TDI,APT-B7 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |leukemogenesis | ||
+ | |Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289662 HSALNT0289662] | ||
+ | |[[C15orf2]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Angelman syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290097 HSALNT0290097] | ||
+ | |[[NPAP1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Angelman syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217406 HSALNT0217406] | ||
+ | |[[NONHSAT040875]] | ||
+ | |NCRNA00199 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Prader-Willi syndrome | ||
+ | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289227 HSALNT0289227] | ||
+ | |[[NONHSAT040920]] | ||
+ | |NCRNA00198 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Prader-Willi syndrome | ||
+ | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262816 HSALNT0262816] | ||
+ | |[[MIMT1]] | ||
+ | |MIM1,NCRNA00067,LINC00067 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289180 HSALNT0289180] | ||
+ | |[[MIR34AHG]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289357 HSALNT0289357] | ||
+ | |[[LINC02570]] | ||
+ | |XXbac-BPG27H4.8 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |MHC-associated diseases | ||
+ | |Immune System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290177 HSALNT0290177] | ||
+ | |[[RNY1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cervix cancer;prostate cancer;colorectal cancer;bladder cancer;kidney cancer;lung cancer | ||
+ | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289378 HSALNT0289378] | ||
+ | |[[NKX2-2-AS1]] | ||
+ | |NKX2-2AS | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290151 HSALNT0290151] | ||
+ | |[[NONHSAT023851]] | ||
+ | |FJ515872.1,NONHSAT023851 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289607 HSALNT0289607] | ||
+ | |[[Anti-NOS2A]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |meningioma;glioblastoma | ||
+ | |Neoplasms;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289687 HSALNT0289687] | ||
+ | |[[CDKN1A-AS1]] | ||
+ | |p21NAT | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0116668 HSALNT0116668] | ||
+ | |[[RPS6KA2-AS1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289384 HSALNT0289384] | ||
+ | |[[PAPPA-AS2]] | ||
+ | |AGU1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262802 HSALNT0262802] | ||
+ | |[[ZIM2-AS1]] | ||
+ | |ZIM2as | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289824 HSALNT0289824] | ||
+ | |[[Lnc-DLX5-3:1]] | ||
+ | |Evf-2,Dlx6as1,Dlx6os1,ENSG00000231764, ENST00000430027.2,lnc-DLX5-3:1 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289481 HSALNT0289481] | ||
+ | |[[ADORA2A-AS1]] | ||
+ | |C22orf45,FLJ34651 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290146 HSALNT0290146] | ||
+ | |[[POU5F1P4]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290033 HSALNT0290033] | ||
+ | |[[LSINCT1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290034 HSALNT0290034] | ||
+ | |[[LSINCT10]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290035 HSALNT0290035] | ||
+ | |[[LSINCT11]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290036 HSALNT0290036] | ||
+ | |[[LSINCT12]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290037 HSALNT0290037] | ||
+ | |[[LSINCT2]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290038 HSALNT0290038] | ||
+ | |[[LSINCT3]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290039 HSALNT0290039] | ||
+ | |[[LSINCT4]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290041 HSALNT0290041] | ||
+ | |[[LSINCT6]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290042 HSALNT0290042] | ||
+ | |[[LSINCT7]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290043 HSALNT0290043] | ||
+ | |[[LSINCT8]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290044 HSALNT0290044] | ||
+ | |[[LSINCT9]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289676 HSALNT0289676] | ||
+ | |[[NONHSAT016928]] | ||
+ | |FLJ31066,NONHSAT016928,lnc-FANK1-3:1 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290032 HSALNT0290032] | ||
+ | |[[LRRC3DN]] | ||
+ | |C21orf30,DKFZP434C128 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266984 HSALNT0266984] | ||
+ | |[[SNHG11]] | ||
+ | |C20orf198,LINC00101,NCRNA00101 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |obesity | ||
+ | |Nutritional and Metabolic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289880 HSALNT0289880] | ||
+ | |[[NONHSAT113225]] | ||
+ | |NONHSAT113225,ENSG00000220635 | ||
+ | |ceRNA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0006368 HSALNT0006368] | ||
+ | |[[ENST00000444042.2]] | ||
+ | |ncRNA-a3 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027470 HSALNT0027470] | ||
+ | |[[ENST00000417473.2]] | ||
+ | |ncRNA-a5 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289066 HSALNT0289066] | ||
+ | |[[ENST00000429328.2]] | ||
+ | |PDZK1IP1-AS1,ncRNA-a4 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289936 HSALNT0289936] | ||
+ | |[[NONHSAT059436]] | ||
+ | |ROR,lincRNA-ST8SIA3,ENSG00000258609,NONHSAT059436 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289705 HSALNT0289705] | ||
+ | |[[CHL1-AS2]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |adolescent idiopathic scoliosis | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076084 HSALNT0076084] | ||
+ | |[[SEC24B-AS1]] | ||
+ | |1/2-SBSRNA4 | ||
+ | |siRNA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290137 HSALNT0290137] | ||
+ | |[[PDZRN3-AS1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |type 2 diabetes | ||
+ | |Nutritional and Metabolic Diseases;Endocrine System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290237 HSALNT0290237] | ||
+ | |[[SCAANT1]] | ||
+ | |ATXN7-AS1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |spinocerebellar ataxia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289594 HSALNT0289594] | ||
+ | |[[AK123790]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289911 HSALNT0289911] | ||
+ | |[[LINC01451]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290401 HSALNT0290401] | ||
+ | |[[ZNF350-AS1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289845 HSALNT0289845] | ||
+ | |[[GADD45G]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pituitary adenoma | ||
+ | |Endocrine System Diseases;Neoplasms;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289410 HSALNT0289410] | ||
+ | |[[Lnc-RASA1-3:23]] | ||
+ | |AK082072,linc-POLR3G-8,ENSG00000247828 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289736 HSALNT0289736] | ||
+ | |[[DAPK1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Pancreatic ductal adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290048 HSALNT0290048] | ||
+ | |[[MAP3K14]] | ||
+ | |MAP3K14 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Pancreatic ductal adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290150 HSALNT0290150] | ||
+ | |[[PPP3CB]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Pancreatic ductal adenocarcinoma | ||
+ | |Neoplasms | ||
|- | |- | ||
− | |'' | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0151531 HSALNT0151531] |
− | |[[ | + | |[[DAPK1-IT1]] |
− | | | + | |NA |
− | | | + | |NA |
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288990 HSALNT0288990] | ||
+ | |[[GDNF-AS1]] | ||
+ | |GDNFOS | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |Alzheimer's disease | ||
+ | |Mental Disorders;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029702 HSALNT0029702] | ||
+ | |[[BIRC6-AS2]] | ||
+ | |megamind | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029692 HSALNT0029692] | ||
+ | |[[BIRC6-AS1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289310 HSALNT0289310] | ||
+ | |[[LINC00854]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290332 HSALNT0290332] | ||
+ | |[[Uc.73]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289841 HSALNT0289841] | ||
+ | |[[FR0257520]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290104 HSALNT0290104] | ||
+ | |[[NRG1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289689 HSALNT0289689] | ||
+ | |[[CDKN2B-AS11]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process;developmental process | ||
+ | |stroke | ||
+ | |Cardiovascular Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289690 HSALNT0289690] | ||
+ | |[[CDKN2B-AS12]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |glioma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289691 HSALNT0289691] | ||
+ | |[[CDKN2B-AS13]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |plexiform neurofibroma | ||
+ | |Neoplasms;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289697 HSALNT0289697] | ||
+ | |[[CDKN2B-AS7]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |acute lymphoblastic leukemia | ||
+ | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289826 HSALNT0289826] | ||
+ | |[[FADS1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lipid metabolism disorder | ||
+ | |Nutritional and Metabolic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289698 HSALNT0289698] | ||
+ | |[[CDKN2B-AS8]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |melanoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289696 HSALNT0289696] | ||
+ | |[[CDKN2B-AS6]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |neuroblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289699 HSALNT0289699] | ||
+ | |[[CDKN2B-AS9]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289688 HSALNT0289688] | ||
+ | |[[CDKN2B-AS10]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |stroke | ||
+ | |Cardiovascular Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288950 HSALNT0288950] | ||
+ | |[[ENST00000456816]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |clear cell renal cell cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290021 HSALNT0290021] | ||
+ | |[[LOC389332]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |clear cell renal cell cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290306 HSALNT0290306] | ||
+ | |[[TMEM72]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |clear cell renal cell cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289641 HSALNT0289641] | ||
+ | |[[BC029135]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal clear cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290374 HSALNT0290374] | ||
+ | |[[X91348]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal clear cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289694 HSALNT0289694] | ||
+ | |[[CDKN2B-AS4]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289692 HSALNT0289692] | ||
+ | |[[CDKN2B-AS2]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |coronary heart disease | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289693 HSALNT0289693] | ||
+ | |[[CDKN2B-AS3]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |intracranial aneurysm | ||
+ | |Cardiovascular Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289695 HSALNT0289695] | ||
+ | |[[CDKN2B-AS5]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |type 2 diabetes | ||
+ | |Nutritional and Metabolic Diseases;Endocrine System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290319 HSALNT0290319] | ||
+ | |[[T-UCRs]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |neuroblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289530 HSALNT0289530] | ||
+ | |[[51A]] | ||
+ | |NA | ||
+ | |splicing regulation | ||
+ | |pathogenic process | ||
+ | |Alzheimer's disease | ||
+ | |Mental Disorders;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290163 HSALNT0290163] | ||
+ | |[[RAB4B-EGLN2]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290167 HSALNT0290167] | ||
+ | |[[RERT]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0265263 HSALNT0265263] | ||
+ | |[[LINC00237]] | ||
+ | |NCRNA00237 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |macrocephaly;obesity | ||
+ | |Musculoskeletal Diseases;Pathological Conditions, Signs and Symptoms;Nutritional and Metabolic Diseases;Physiological Phenomena | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267186 HSALNT0267186] | ||
+ | |[[LINC01370]] | ||
+ | |HI-LNC25,HILNC25 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |type 2 diabetes | ||
+ | |Nutritional and Metabolic Diseases;Endocrine System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289114 HSALNT0289114] | ||
+ | |[[LINC01574]] | ||
+ | |HI-LNC12,TCONS_00009551 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |type 2 diabetes | ||
+ | |Nutritional and Metabolic Diseases;Endocrine System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290159 HSALNT0290159] | ||
+ | |[[PTHLH]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |brachydactyly | ||
+ | |Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189394 HSALNT0189394] | ||
+ | |[[NONHSAT028496]] | ||
+ | |CISTR-ACT,CISTRACT,re52431 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |brachydactyly | ||
+ | |Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289862 HSALNT0289862] | ||
+ | |[[HELLPAR]] | ||
+ | |LINC-HELLP | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |HELLP syndrome | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289904 HSALNT0289904] | ||
+ | |[[LINC01125]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |uremia | ||
+ | |Male Urogenital Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289544 HSALNT0289544] | ||
+ | |[[AC002511.1]] | ||
+ | |LINC01531 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |enterovirus 71 infection | ||
+ | |Virus Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289609 HSALNT0289609] | ||
+ | |[[AP000688.29]] | ||
+ | |AP000688.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |enterovirus 71 infection | ||
+ | |Virus Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289832 HSALNT0289832] | ||
+ | |[[FFAR2]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |enterovirus 71 infection | ||
+ | |Virus Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290222 HSALNT0290222] | ||
+ | |[[RP4-620F22.3]] | ||
+ | |AC099063.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |enterovirus 71 infection | ||
+ | |Virus Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290227 HSALNT0290227] | ||
+ | |[[RP5-843L14.1]] | ||
+ | |LINC01716 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |enterovirus 71 infection | ||
+ | |Virus Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287285 HSALNT0287285] | ||
+ | |[[MAGEA8-AS1]] | ||
+ | |RP5-869M20.2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289019 HSALNT0289019] | ||
+ | |[[LHX5-AS1]] | ||
+ | |locus4010 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288902 HSALNT0288902] | ||
+ | |[[CAPN10-AS1]] | ||
+ | |CAPN10-DT,locus959 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289404 HSALNT0289404] | ||
+ | |[[STAM-AS1]] | ||
+ | |locus3182 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0148276 HSALNT0148276] | ||
+ | |[[PTENP1-AS]] | ||
+ | |PTENpg1-asRNA | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289562 HSALNT0289562] | ||
+ | |[[AF116616]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289589 HSALNT0289589] | ||
+ | |[[AK094838]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289620 HSALNT0289620] | ||
+ | |[[ASLNC00339]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289629 HSALNT0289629] | ||
+ | |[[BC002350]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289651 HSALNT0289651] | ||
+ | |[[BC091525]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289652 HSALNT0289652] | ||
+ | |[[BE503655]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289753 HSALNT0289753] | ||
+ | |[[ENO1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289835 HSALNT0289835] | ||
+ | |[[FKBP10]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290064 HSALNT0290064] | ||
+ | |[[MYHAS]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289985 HSALNT0289985] | ||
+ | |[[LncRNA-LALR1]] | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |liver cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091577 HSALNT0091577] | ||
+ | |[[NR2F1-AS1]] | ||
+ | |FLJ42709 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289709 HSALNT0289709] | ||
+ | |[[CK19]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289943 HSALNT0289943] | ||
+ | |[[Llme23]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |melanoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289553 HSALNT0289553] | ||
+ | |[[AC096655.1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289178 HSALNT0289178] | ||
+ | |[[ENST00000602507.1]] | ||
+ | |Lnc-Ang362 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Ang II-associated cardiovascular disease | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289261 HSALNT0289261] | ||
+ | |[[STX18-AS1]] | ||
+ | |LOC100507266 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |atrial septal defect | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289849 HSALNT0289849] | ||
+ | |[[GHSR]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289210 HSALNT0289210] | ||
+ | |[[ENST00000452148.2]] | ||
+ | |PCAN-R2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289702 HSALNT0289702] | ||
+ | |[[CES1P1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289892 HSALNT0289892] | ||
+ | |[[LINC00210]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290006 HSALNT0290006] | ||
+ | |[[LOC100506974]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290219 HSALNT0290219] | ||
+ | |[[RP3-508I15.14]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290243 HSALNT0290243] | ||
+ | |[[SLC6A6]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290342 HSALNT0290342] | ||
+ | |[[Uc003bgl.1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289075 HSALNT0289075] | ||
+ | |[[LINC00970]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211868 HSALNT0211868] | ||
+ | |[[SALRNA1]] | ||
+ | |SAL-RNA1,XLOC_023166 | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222267 HSALNT0222267] | ||
+ | |[[SALRNA3]] | ||
+ | |SAL-RNA3,XLOC_025918 | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222274 HSALNT0222274] | ||
+ | |[[SALRNA2]] | ||
+ | |SAL-RNA2,XLOC_025931 | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289428 HSALNT0289428] | ||
+ | |[[NONHSAT076558]] | ||
+ | |GPR1-AS1,GPR1AS | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0226207 HSALNT0226207] | ||
+ | |[[LINC00235]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |anorexia nervosa | ||
+ | |Mental Disorders | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289526 HSALNT0289526] | ||
+ | |[[1B FGF-antisense transcripts]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometriosis | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290171 HSALNT0290171] | ||
+ | |[[RNA polymerase III-dependent lncRNAs]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |diffuse cerebral hypomyelination | ||